[MDGL] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -30.26%
YoY- -139.62%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -59,123 -57,963 -49,023 -36,135 -27,740 -21,429 -19,699 107.37%
Tax -116 0 -1,319 0 -28 0 0 -
NP -59,123 -57,963 -49,023 -36,135 -27,740 -21,429 -19,699 107.37%
Tax Rate - - - - - - - -
Total Cost 59,123 57,963 49,023 36,135 27,740 21,429 19,699 107.37%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -3.82 -3.75 -3.18 -2.34 -1.80 -1.39 -1.28 106.59%
EPS Diluted -3.82 -3.75 -3.18 -2.34 -1.80 -1.39 -1.28 106.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.